Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Mitochondrial noncoding RNA-regulatory network in cardiovascular disease
Amela Jusic
,
Yvan Devaux
*
, the EU-CardioRNA COST Action (CA17129)
*
Corresponding author for this work
Cardiovascular Research Unit
Research output
:
Contribution to journal
›
Review article
›
peer-review
91
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Mitochondrial noncoding RNA-regulatory network in cardiovascular disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Myocardial Infarction
16%
Biomarker Potential
16%
Cardiac Hypertrophy
16%
Cardiac Mechanical Function
16%
Cardiomyocytes
16%
Cardiovascular Disease
100%
Cardiovascular Pathology
16%
Cardiovascular Pathophysiology
16%
Cellular Homeostasis
16%
Clinical Application
16%
Disease Phenotype
16%
Energy Status
16%
Energy Supply
16%
Expression Level
16%
Gene Expression
16%
Gene Regulatory Network
33%
Glycolysis
16%
Heart Failure
16%
High Energy
16%
Hypertension
16%
Long Non-coding RNA (LncRNA)
33%
Mitochondria
16%
Mitochondrial DNA
16%
Mitochondrial Dysfunction
16%
Mitochondrial Function
33%
Mitochondrial Integrity
16%
Mitochondrial Metabolism
33%
Mitochondrial microRNA
33%
Mitochondrial Oxidative Metabolism
16%
Molecular Pathways
16%
Non-coding RNA (ncRNA)
100%
Nuclear Genome
16%
RNA Regulatory Network
100%
Therapeutic Potential
16%
Traditional View
16%
Biochemistry, Genetics and Molecular Biology
Adenosine Triphosphate
33%
Aerobic Metabolism
16%
Cardiac Muscle Cell
16%
Expression Level
16%
Glycolysis
16%
Homeostasis
16%
Long Noncoding RNA
33%
MicroRNA
33%
Mitochondrial Disorder
16%
Mitochondrial DNA
16%
Mitochondrial Genome
16%
Mitochondrial Respiration
33%
Mitochondrion
16%
Non-Coding RNA
100%
Regulatory Network
100%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
16%
Adenosine Triphosphate
33%
Biological Marker
16%
Cardiovascular Disease
100%
Congestive Heart Failure
16%
Diseases
16%
Heart Ventricle Hypertrophy
16%
Hypertension
16%
Long Untranslated RNA
33%
microRNA
33%
Mitochondrial DNA
16%
Pathogenesis
33%
Untranslated RNA
100%
Neuroscience
Adenosine Triphosphate
25%
Biological Marker
12%
Cardiovascular System
100%
Glycolysis
12%
Hypertension
12%
Long Non-Coding RNA
25%
Metabolic Pathway
12%
MicroRNA
25%
Mitochondrial DNA
12%
Mitochondrial Function
25%
Mitochondrial Respiration
25%
Mitochondrion
12%
Myocardial Infarction
12%
Non-Coding RNA
100%